[SCHEDULE 13G] PureTech Health plc American SEC Filing
Citigroup and several of its subsidiaries report a collective beneficial ownership of 13,220,374 ordinary shares of PureTech Health plc, representing 5.5% of the class. The filing names five Citigroup reporting persons and discloses that the position carries shared voting power and shared dispositive power; no sole voting or dispositive authority is reported.
The statement indicates the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing also describes the chain of ownership among the Citigroup entities that hold the position.
Citigroup e diverse sue controllate dichiarano una titolarit脿 economica collettiva di 13,220,374 azioni ordinarie di PureTech Health plc, pari al 5.5% della classe. Il deposito nomina cinque soggetti segnalanti di Citigroup e indica che la posizione comporta potere di voto condiviso e potere di disposizione condiviso; non 猫 riportata alcuna autorit脿 esclusiva di voto o di disposizione.
La dichiarazione specifica che i titoli sono detenuti nell'ordinario corso degli affari e non sono stati acquisiti per modificare o influenzare il controllo dell'emittente. Il deposito descrive inoltre la catena di propriet脿 tra le entit脿 Citigroup che detengono la posizione.
Citigroup y varias de sus subsidiarias informan una propiedad beneficiaria colectiva de 13,220,374 acciones ordinarias de PureTech Health plc, que representan el 5.5% de la clase. La presentaci贸n nombra a cinco personas informantes de Citigroup y revela que la posici贸n conlleva poder de voto compartido y poder de disposici贸n compartido; no se informa autoridad exclusiva de voto ni de disposici贸n.
La declaraci贸n indica que los valores se mantienen en el curso ordinario del negocio y no se adquirieron para cambiar o influir en el control del emisor. La presentaci贸n tambi茅n describe la cadena de propiedad entre las entidades de Citigroup que ostentan la posici贸n.
鞁滍嫲攴鸽９瓿� 攴� 鞐煬 鞛愴殞靷姅 PureTech Health plc鞚� 13,220,374 氤错喌欤�毳� 歆戨嫧鞝� 鞁れ唽鞙犽 氤挫湢頃橁碃 鞛堨溂氅� 鞚措姅 頃措嫻 膦呺鞚� 5.5%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 鞁滍嫲攴鸽９鞚� 氤搓碃鞚胳澊 雼れ劘 氇呾溂搿� 旮办灛霅橃柎 鞛堦碃, 頃措嫻 歆�鞙勲姅 瓿惦彊 鞚橁舶甓�瓿� 瓿惦彊 觳橂秳甓�鞚� 鞛堨潓鞚� 氚濏瀳氅� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潃 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
靹彪獏靹滊姅 鞚� 歃濌秾霌れ澊 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅橁碃 鞛堨溂氅� 氚滍枆須岇偓鞚� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃橁赴 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃╇媹雼�. 鞝滌稖靹滊電� 霕愴暅 頃措嫻 歆�鞙勲ゼ 氤挫湢頃� 鞁滍嫲攴鸽９ 瓿勳棿靷摛 臧勳潣 靻岇湢 甑“毳� 靹る獏頃╇媹雼�.
Citigroup et plusieurs de ses filiales d茅clarent une propri茅t茅 b茅n茅ficiaire collective de 13,220,374 actions ordinaires de PureTech Health plc, repr茅sentant 5.5% de la cat茅gorie. Le dossier nomme cinq personnes d茅clarantes de Citigroup et pr茅cise que la position comporte un pouvoir de vote partag茅 et un pouvoir de disposition partag茅 ; aucune autorit茅 exclusive de vote ou de disposition n'est signal茅e.
La d茅claration indique que les titres sont d茅tenus dans le cours normal des affaires et n'ont pas 茅t茅 acquis pour modifier ou influencer le contr么le de l'茅metteur. Le dossier d茅crit 茅galement la cha卯ne de propri茅t茅 entre les entit茅s de Citigroup d茅tenant la position.
Citigroup und mehrere seiner Tochtergesellschaften melden eine gemeinsame wirtschaftliche Beteiligung von 13,220,374 Stammaktien an PureTech Health plc, was 5.5% der Klasse entspricht. Die Meldung nennt f眉nf meldende Personen von Citigroup und gibt an, dass die Position 眉ber gemeinsames Stimmrecht und gemeinsame Verf眉gungsgewalt verf眉gt; alleinige Stimm- oder Verf眉gungsbefugnisse werden nicht angegeben.
In der Erkl盲rung hei脽t es, dass die Wertpapiere im normalen Gesch盲ftsgang gehalten werden und nicht zum Zweck des Wechsels oder der Beeinflussung der Kontrolle des Emittenten erworben wurden. Die Meldung beschreibt au脽erdem die Eigentumskette zwischen den Citigroup-Gesellschaften, die die Position halten.
- Institutional ownership above 5% (13,220,374 shares) signals material investor interest in PureTech Health plc.
- Filing filed on Schedule 13G, indicating the holders assert a passive investment intent and certify the position is not to influence control.
- No sole voting or dispositive power reported; all authority is represented as shared across Citigroup entities.
- Holding is a minority stake (5.5%), which does not confer unilateral control or definitive governance influence.
Insights
TL;DR: Citigroup group reports a passive, material 5.5% stake (13.22M shares) with shared voting and dispositive power.
The Schedule 13G shows a meaningful institutional position above the 5% reporting threshold, reported on a form used for passive holdings. The filing discloses 13,220,374 shares (5.5%) and specifies shared voting and dispositive authority across Citigroup entities rather than any sole control. For investors, this documents substantive institutional interest without an expressed intent to influence corporate control.
TL;DR: Shared voting/dispositive power across Citigroup subsidiaries; filing affirms ordinary-course, non-control holding.
The filing identifies the internal ownership chain among Citigroup entities and classifies the filers as a foreign financial institution. It explicitly states the position is held in the ordinary course of business and not to affect control. The absence of sole voting or dispositive power implies the stake is structured within group custody/activities rather than as an activist or controlling block.
Citigroup e diverse sue controllate dichiarano una titolarit脿 economica collettiva di 13,220,374 azioni ordinarie di PureTech Health plc, pari al 5.5% della classe. Il deposito nomina cinque soggetti segnalanti di Citigroup e indica che la posizione comporta potere di voto condiviso e potere di disposizione condiviso; non 猫 riportata alcuna autorit脿 esclusiva di voto o di disposizione.
La dichiarazione specifica che i titoli sono detenuti nell'ordinario corso degli affari e non sono stati acquisiti per modificare o influenzare il controllo dell'emittente. Il deposito descrive inoltre la catena di propriet脿 tra le entit脿 Citigroup che detengono la posizione.
Citigroup y varias de sus subsidiarias informan una propiedad beneficiaria colectiva de 13,220,374 acciones ordinarias de PureTech Health plc, que representan el 5.5% de la clase. La presentaci贸n nombra a cinco personas informantes de Citigroup y revela que la posici贸n conlleva poder de voto compartido y poder de disposici贸n compartido; no se informa autoridad exclusiva de voto ni de disposici贸n.
La declaraci贸n indica que los valores se mantienen en el curso ordinario del negocio y no se adquirieron para cambiar o influir en el control del emisor. La presentaci贸n tambi茅n describe la cadena de propiedad entre las entidades de Citigroup que ostentan la posici贸n.
鞁滍嫲攴鸽９瓿� 攴� 鞐煬 鞛愴殞靷姅 PureTech Health plc鞚� 13,220,374 氤错喌欤�毳� 歆戨嫧鞝� 鞁れ唽鞙犽 氤挫湢頃橁碃 鞛堨溂氅� 鞚措姅 頃措嫻 膦呺鞚� 5.5%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 鞁滍嫲攴鸽９鞚� 氤搓碃鞚胳澊 雼れ劘 氇呾溂搿� 旮办灛霅橃柎 鞛堦碃, 頃措嫻 歆�鞙勲姅 瓿惦彊 鞚橁舶甓�瓿� 瓿惦彊 觳橂秳甓�鞚� 鞛堨潓鞚� 氚濏瀳氅� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潃 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
靹彪獏靹滊姅 鞚� 歃濌秾霌れ澊 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅橁碃 鞛堨溂氅� 氚滍枆須岇偓鞚� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃橁赴 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃╇媹雼�. 鞝滌稖靹滊電� 霕愴暅 頃措嫻 歆�鞙勲ゼ 氤挫湢頃� 鞁滍嫲攴鸽９ 瓿勳棿靷摛 臧勳潣 靻岇湢 甑“毳� 靹る獏頃╇媹雼�.
Citigroup et plusieurs de ses filiales d茅clarent une propri茅t茅 b茅n茅ficiaire collective de 13,220,374 actions ordinaires de PureTech Health plc, repr茅sentant 5.5% de la cat茅gorie. Le dossier nomme cinq personnes d茅clarantes de Citigroup et pr茅cise que la position comporte un pouvoir de vote partag茅 et un pouvoir de disposition partag茅 ; aucune autorit茅 exclusive de vote ou de disposition n'est signal茅e.
La d茅claration indique que les titres sont d茅tenus dans le cours normal des affaires et n'ont pas 茅t茅 acquis pour modifier ou influencer le contr么le de l'茅metteur. Le dossier d茅crit 茅galement la cha卯ne de propri茅t茅 entre les entit茅s de Citigroup d茅tenant la position.
Citigroup und mehrere seiner Tochtergesellschaften melden eine gemeinsame wirtschaftliche Beteiligung von 13,220,374 Stammaktien an PureTech Health plc, was 5.5% der Klasse entspricht. Die Meldung nennt f眉nf meldende Personen von Citigroup und gibt an, dass die Position 眉ber gemeinsames Stimmrecht und gemeinsame Verf眉gungsgewalt verf眉gt; alleinige Stimm- oder Verf眉gungsbefugnisse werden nicht angegeben.
In der Erkl盲rung hei脽t es, dass die Wertpapiere im normalen Gesch盲ftsgang gehalten werden und nicht zum Zweck des Wechsels oder der Beeinflussung der Kontrolle des Emittenten erworben wurden. Die Meldung beschreibt au脽erdem die Eigentumskette zwischen den Citigroup-Gesellschaften, die die Position halten.
FAQ
How many PureTech (PRTC) shares does Citigroup report owning?
What percentage of PureTech (PRTC) does that represent?
Does Citigroup have sole voting or dispositive power over these shares?
Is the holding reported as intended to influence control of PureTech (PRTC)?
Which Citigroup entities are named as reporting persons?
